Evaluating Conformal Reliability of Pathway-Level Transcriptomic Signatures Under Cross-Cohort Shift in Sepsis Mortality Prediction

Pathway-level analysis provides more reliable predictions across different hospitals: While gene-level models showed slightly better overall accuracy, pathway-level representations (grouping genes by biological function) maintained more consistent and trustworthy predictions when applied to patient data from different hospitals, suggesting they're more practical for real-world deployment in diverse medical settings.

Standard testing methods don't catch real-world problems: Models that performed well in traditional within-hospital evaluations showed significant performance degradation when tested across different hospitals, highlighting that responsible AI evaluation for medical applications requires testing across multiple independent datasets to identify potential failures before deployment.

Uncertainty estimates matter as much as predictions: The study found that pathway-level models not only made better predictions but also provided more reliable confidence measures about those predictions under cross-cohort conditions—a critical feature for clinicians who need to know when to trust an AI system's recommendations versus when to seek additional expert judgment.

Biological interpretability correlates with robustness: Pathway-level signatures that could be traced to known immune and host-defense biological processes showed greater stability across different patient populations, suggesting that AI models grounded in established biological knowledge may be more trustworthy for clinical translation than purely data-driven approaches.

Multiple validation approaches are necessary: The research employed conformal prediction, calibration analysis, and selective prediction methods alongside traditional metrics, demonstrating that comprehensive evaluation frameworks—not single performance metrics—are essential for assessing whether AI systems are truly ready for clinical use.